Forest Ends Celexa Rebates; Lexapro Price To Managed Care Is 25% Lower
Executive Summary
The price differential to managed care between Celexa and Lexapro has widened to 25% since Forest terminated Celexa's rebate program, President Kenneth Goodman said during a Jan. 20 earnings call
You may also be interested in...
Forest Expects Lexapro To Gain Market Share Despite Lilly Cymbalta Launch
Forest is expecting continued market share gains for Lexapro as it prepares for the upcoming launch of Lilly's antidepressant Cymbalta
Forest Lexapro “Re-Launch” For Generalized Anxiety Set For Mid-January
Forest will begin promotion of Lexapro for generalized anxiety disorder in mid-January
Namenda Price Set Below Aricept; Forest Wants To Drive Combination Use
Forest plans to price Namenda at a mid-single digit discount to Pfizer's Aricept to encourage uptake of the Alzheimer's disease drug as add-on therapy